
Episode 199 - October 16, 2026
16 Oct 2026
A weekly discussion of all things biotech – breaking news, data deals and FDA actions – with a community of biotech industry leaders and experts. Join us live every Friday on X Spaces at @BiotechCH.


The biotech sector maintains strong year-to-date performance despite recent market choppiness and macroeconomic uncertainty, with the XBI index significantly outperforming broader benchmarks. Key industry developments include a major collaboration between Regeneron and Sanofi to extend their Dupixent lifecycle, and a s...
Follow this podcast in Podwise
Sign in to get AI summaries, transcripts and mind maps for any episode, including new ones.
